(Q33713596)

28 July 2017

1 reference

title

Therapy for pneumococcal infection at the millennium: doubts and certainties (English)

1 reference

28 July 2017

main subject

pneumococcal infection

1 reference

Ball P

1

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

American Journal of Medicine

28 July 2017

published in

1 reference

28 July 2017

volume

107

1 reference

28 July 2017

issue

1A

1 reference

28 July 2017

page(s)

77S-85S

1 reference

PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Maxwell Finland Lecture. Random gleanings from a life with the pneumococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

30 years of penicillin-resistant S pneumoniae: myth or reality?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Increased resistance to penicillin of pneumococci isolated from man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Antibiotic resistance in Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Epidemiology of penicillin resistant pneumococci in Iceland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Rapid emergence of penicillin-resistant pneumococci in Hong Kong

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Emergence of Antibiotic Resistance In Hospitals, 1935-1975

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

A global gene pool for high-level cephalosporin resistance in commensal Streptococcus species and Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Effect of nutrition improvement project on morbidity from infectious diseases in preschool children in Vietnam: comparison with control commune

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Spread of multidrug-resistant Streptococcus pneumoniae among hospitalized children in Slovakia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Penicillin-resistant Streptococcus pneumoniae in acute otitis media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Multiply resistant pneumococcus causing meningitis: its epidemiology within a day-care centre

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Colonization with penicillin-resistant Streptococcus pneumoniae in a child-care center.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Pharmacokinetics and pharmacodynamics of antibiotics in otitis media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Efficacy of amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Clinical outcome of acute otitis media caused by pneumococci with decreased susceptibility to penicillin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Penicillin-resistant pneumococcal meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Appearance of resistance to beta-lactam antibiotics during therapy for Streptococcus pneumoniae meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Mathematical examination of dual individualization principles (II): The rate of bacterial eradication at the same area under the inhibitory curve is more rapid for ciprofloxacin than for cefmenoxime.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Lower respiratory tract infection therapy--the role of ciprofloxacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Quinolones in chest infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Infectious Complications with Respiratory Pathogens despite Ciprofloxacin Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Oral empiric treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing sparfloxacin with roxithromycin. The Scandinavian Sparfloxacin Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Efficacy and safety of grepafloxacin 600 mg daily for 10 days in patients with community-acquired pneumonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Influence of patients' expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

In-vitro activity of the fluoroquinolone trovafloxacin against penicillin-susceptible and -resistant Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: the Alexander Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Activity of DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and OPC-17116 against 112 penicillin-susceptible and -resistant pneumococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Emerging resistance to antimicrobial agents in gram-positive bacteria. Pneumococci.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

In vitro activity of BAY 12-8039, a new 8-methoxyquinolone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900104-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(99)00104-7

1 reference

28 July 2017

1 reference